More than 300 verified incidences of cardiac muscle inflammation among Adolescents and young people after receiving mRNA Covid-19 vaccinations will be reviewed by a group of experts convened by the US government’s top health body. The group, which will be chaired by the Centers for Disease Control and Prevention (CDC), will hear a risk-benefit analysis as researchers look at whether the shots can induce myocarditis and pericarditis, which is inflammation of the heart lining.
Israel was the first to notice a possible connection. CDC director Rochelle Walensky said, “These cases are rare, and the vast majority have fully resolved with rest and supportive care.” The confirmed instances were evaluated after early reports to vaccination safety monitoring systems, and they came from more than 20 million immunized Adolescents and young adults, according to Walensky.
Instead of self-reported data, the new CDC hearing will go deeper into updated data that has been independently validated. “I’m concerned,” Lorry Rubin, director of pediatric infectious diseases at Cohen Children’s Medical Center, said, “but cause and effect has yet to be established.” He added a few examples of adolescent males suffering chest problems a day or two after receiving the second dose of an mRNA vaccination had been seen at his institution. Currently, the Pfizer vaccination is the only one approved for teenagers aged 12 and up.